Prestige Consumer Healthcare (PBH) Asset Writedowns and Impairment (2018 - 2023)

Prestige Consumer Healthcare's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $369.8 million for Q1 2023.

• On a quarterly basis, Asset Writedowns and Impairment rose 34882.97% year-over-year to $369.8 million in Q1 2023; TTM through Sep 2023 was $369.8 million, a 24485.77% increase from a year earlier, with the FY2025 full-year figure at $12.5 million, changed N/A from the prior year.
• Asset Writedowns and Impairment grew to $369.8 million in Q1 2023 per PBH's latest filing, from $1000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $369.8 million in Q1 2023 and bottomed at -$34000.0 in Q1 2020.
• The 5-year median for Asset Writedowns and Impairment is $446000.0 (2022), against an average of $54.8 million.
• Across the five-year window, Asset Writedowns and Impairment sank 100.01% in 2020 and soared 34882.97% in 2023, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $34000.0 in 2019, then jumped by 2335.29% to $828000.0 in 2020, then soared by 80.8% to $1.5 million in 2021, then plunged by 99.93% to $1000.0 in 2022, then surged by 36976900.0% to $369.8 million in 2023.
• Per Business Quant, the three latest PBH Asset Writedowns and Impairment figures stand at $369.8 million (Q1 2023), $1000.0 (Q3 2022), and $446000.0 (Q2 2022).